MARENGO Trademark

Trademark Overview


On Friday, November 5, 2021, a trademark application was filed for MARENGO with the United States Patent and Trademark Office. The USPTO has given the MARENGO trademark a serial number of 97111780. The federal status of this trademark filing is REGISTERED as of Tuesday, December 23, 2025. This trademark is owned by MARENGO THERAPEUTICS, INC.. The MARENGO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the fields of immunology and oncology; pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials for others; research and development services in the field of antibodies; research and development in immunology for the purpose of using antibodies to target malignant solid tumors and to promote protective tumor immunity; research and development in pharmacology for the purpose of triggering cytokine release for the expansion of an antigen-specific memory T cell repertoire for the purpose of treating cancer; medical research services in the field of cancer; medical and scientific research in the field of cancer treatment; medical and scientific research for immune system activation and protection; research and development for the purpose of anti-cancer immune activation therapeutics; medical and scientific research in the fields of immunology and oncology for treating cancer, infectious disease, auto-imm...

General Information


Serial Number97111780
Word MarkMARENGO
Filing DateFriday, November 5, 2021
Status700 - REGISTERED
Status DateTuesday, December 23, 2025
Registration Number8078738
Registration DateTuesday, December 23, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2022

Trademark Statements


Goods and ServicesMedical and scientific research in the fields of immunology and oncology; pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials for others; research and development services in the field of antibodies; research and development in immunology for the purpose of using antibodies to target malignant solid tumors and to promote protective tumor immunity; research and development in pharmacology for the purpose of triggering cytokine release for the expansion of an antigen-specific memory T cell repertoire for the purpose of treating cancer; medical research services in the field of cancer; medical and scientific research in the field of cancer treatment; medical and scientific research for immune system activation and protection; research and development for the purpose of anti-cancer immune activation therapeutics; medical and scientific research in the fields of immunology and oncology for treating cancer, infectious disease, auto-immune disease, and other diseases in connection with immune system dysfunction; research and development of vaccines and medicines

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 16, 2021
Primary Code042
First Use Anywhere DateMonday, August 1, 2022
First Use In Commerce DateMonday, August 1, 2022

Trademark Owner History


Party NameMARENGO THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameMARENGO THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameMARENGO THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Tuesday, November 9, 2021NEW APPLICATION ENTERED
Tuesday, November 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 16, 2022ASSIGNED TO EXAMINER
Tuesday, August 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 31, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 20, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 21, 2023ASSIGNED TO EXAMINER
Monday, May 15, 2023SOU TEAS EXTENSION RECEIVED
Monday, May 15, 2023SOU EXTENSION 1 FILED
Monday, May 15, 2023SOU EXTENSION 1 GRANTED
Wednesday, May 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 17, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 17, 2023SOU EXTENSION 2 FILED
Tuesday, October 17, 2023SOU EXTENSION 2 GRANTED
Thursday, October 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 3, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 3, 2024SOU EXTENSION 3 FILED
Friday, May 3, 2024SOU EXTENSION 3 GRANTED
Saturday, May 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 14, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 15, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 14, 2024SOU EXTENSION 4 FILED
Wednesday, January 22, 2025SOU EXTENSION 4 GRANTED
Thursday, January 23, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 16, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, April 16, 2025SOU EXTENSION 5 FILED
Thursday, April 24, 2025SOU EXTENSION 5 GRANTED
Friday, April 25, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 12, 2025TEAS STATEMENT OF USE RECEIVED
Wednesday, November 12, 2025USE AMENDMENT FILED
Thursday, November 13, 2025STATEMENT OF USE PROCESSING COMPLETE
Thursday, December 4, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, December 4, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 23, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, December 23, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED